PMID- 2517856
OWN - NLM
STAT- MEDLINE
DCOM- 19900727
LR  - 20141120
IS  - 0066-9458 (Print)
IS  - 0066-9458 (Linking)
VI  - 102
DP  - 1989
TI  - Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type 
      plasminogen activator (scuPA) conjugated to an antifibrin antibody.
PG  - 7-12
FAU - Bode, C
AU  - Bode C
AD  - Medizinische Klinik III, Universitat Heidelberg, Germany.
FAU - Runge, M
AU  - Runge M
FAU - Eberle, T
AU  - Eberle T
FAU - Freitag, M
AU  - Freitag M
FAU - Kubler, W
AU  - Kubler W
FAU - Haber, E
AU  - Haber E
LA  - eng
GR  - HL-19259/HL/NHLBI NIH HHS/United States
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Research Support, U.S. Gov't, P.H.S.
PL  - United States
TA  - Trans Assoc Am Physicians
JT  - Transactions of the Association of American Physicians
JID - 7506109
RN  - 0 (Fibrinolytic Agents)
RN  - 0 (Immunoglobulin Fab Fragments)
RN  - 9001-31-4 (Fibrin)
RN  - EC 3.4.21.- (Plasminogen Activators)
RN  - EC 3.4.21.73 (Urokinase-Type Plasminogen Activator)
SB  - IM
MH  - Animals
MH  - Fibrin/immunology
MH  - Fibrinolysis/*drug effects
MH  - Fibrinolytic Agents
MH  - Humans
MH  - Immunoglobulin Fab Fragments/administration & dosage
MH  - In Vitro Techniques
MH  - Plasminogen Activators/administration & dosage/*pharmacology
MH  - Rabbits
MH  - Urokinase-Type Plasminogen Activator/administration & dosage/*pharmacology
EDAT- 1989/01/01 00:00
MHDA- 1989/01/01 00:01
CRDT- 1989/01/01 00:00
PHST- 1989/01/01 00:00 [pubmed]
PHST- 1989/01/01 00:01 [medline]
PHST- 1989/01/01 00:00 [entrez]
PST - ppublish
SO  - Trans Assoc Am Physicians. 1989;102:7-12.